GSO ASTM F639:2021

Gulf Standard   Current Edition
· Approved on 01 July 2021 ·

Standard Specification for Polyethylene Plastics for Medical Applications

GSO ASTM F639:2021 Files

English 3 Pages
Current Edition Reference Language

GSO ASTM F639:2021 Scope

This specification covers the properties for polyethylene plastics for use in medical device applications involving human tissue contact devices, short term indwellings, and fluid transfer devices. Biocompatibility tests must be conducted on the final products as the biocompatibility of these materials as a class has not been established. Plyethylene plastics should consist of basic polymers with ethylene as essentially the sole monomer. The compound may contain optional adjuvant substances required in polymer production or fabrication. The final compound should yield a consistent absorption spectrum characteristic of the established formulation. The polyethylene plastics should be tested using the specified physical test procedures for density, melt flow, tensile properties, compressive properties, stiffness, flexural fatigue, and other flexural properties.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants
GSO 2302:2022
 
Gulf Standard
Cosmetic Products – Face Masks

Recently Published from Health Sector

GSO ISO 17069:2024
ISO 17069:2020 
Gulf Standard
Accessible design — Consideration and assistive products for accessible meeting
GSO ISO 11978:2024
ISO 11978:2017 
Gulf Standard
Ophthalmic optics — Contact lenses and contact lens care products — Labelling
GSO ISO 11608-6:2024
ISO 11608-6:2022 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 6: On-body delivery systems
GSO ISO 16256:2024
ISO 16256:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases